Point-of-care coagulation management in intensive care medicine
2013; BioMed Central; Volume: 17; Issue: 2 Linguagem: Inglês
10.1186/cc12527
ISSN1466-609X
AutoresPatrick Meybohm, Kai Zacharowski, Christian Weber,
Tópico(s)Sepsis Diagnosis and Treatment
ResumoCoagulopathy in critically ill patients is common and of multifactorial origin [1]. Coagulopathy-associated risk of bleeding and the use of allogeneic blood products are independent risk factors for morbidity and mortality [2, 3]. Therefore, prompt and correct identification of the underlying causes of these coagulation abnormalities is required, since each coagulation abnormality necessitates very different therapeutic management strategies. Standard laboratory tests of blood coagulation yield only partial diagnostic information, and important coagulation defects, e.g., reduced clot stability, platelet dysfunction, or hyperfibrinolysis, remain undetected.
Referência(s)